retatrutide and kidney function Comparison of the effects of Liraglutide, Tirzepatide, on diabetic disease in db/db mice | Endocrine Retatrutide for weight loss: Study

Tirzepatide deserves respect because it changed the category

doi: 10.1016/j.celrep.2022.111008

fields Lilly, Novo (via the UBT-251 license and an internal NNC program), D&D Pharmatech (DD-03 / DD-15, both linked to Metsera and therefore now Pfizer after the 2025 acquisition), Protagonist, Cascade, and Rani

Tirzepatide is a dual agonist targeting GLP-1R and GIPR Retatrutide adds GCGR activation as a third receptor target

Training Adjustments and Energy Management Training intensity may require adjustment during Retatrutide use, particularly during the initial adaptation period and at higher doses

However, more evidence is needed to clarify their systemic effects and controversial direct hepatic benefits